Back to Search
Start Over
Symptom control.
- Source :
-
Gaceta medica de Mexico [Gac Med Mex] 2022; Vol. 158 (Supl 1), pp. 55-58. - Publication Year :
- 2022
-
Abstract
- In addition to symptoms secondary to splenomegaly, microvascular abnormalities, and thrombohemorrhagic complications, patients with MPN may experience a significant symptom burden attributed to an increase in circulating inflammatory cytokines. These symptoms can be severe and limit quality of life. Therefore, in addition to the prevention of complications, one of the objectives of the treatment of MPN is the control of symptoms.<br /> (Copyright: © 2022 Permanyer.)
Details
- Language :
- English
- ISSN :
- 0016-3813
- Volume :
- 158
- Issue :
- Supl 1
- Database :
- MEDLINE
- Journal :
- Gaceta medica de Mexico
- Publication Type :
- Academic Journal
- Accession number :
- 37734050
- Full Text :
- https://doi.org/10.24875/GMM.M22000809